1. T2 Magnetic Resonance Enables Nanoparticle-Mediated Rapid Detection of Candidemia in Whole Blood
- Author
-
Parris S. Wellman, Michael Min, Lori Anne Neely, Mark John Audeh, Jeffrey J. Coleman, Matthew Blanco, Eleftherios Mylonakis, Thomas Jay Lowery, Adam Suchocki, Vasiliki Demas, Lynell R. Skewis, Daniella Lynn Plourde, Theodora Anagnostou, and Nu Ai Phung
- Subjects
Detection limit ,Analyte ,Pathology ,medicine.medical_specialty ,Magnetic Resonance Spectroscopy ,medicine.diagnostic_test ,Candidemia ,Magnetic resonance imaging ,General Medicine ,Biology ,Polymerase Chain Reaction ,Microbiology ,law.invention ,law ,medicine ,Humans ,Nanoparticles ,Blood culture ,Sample collection ,Pathogen ,Polymerase chain reaction ,Candida ,Whole blood - Abstract
Candida spp. cause both local and disseminated infections in immunocompromised patients. Bloodstream infections of Candida spp., known as "candidemia," are associated with a high mortality rate (40%), which is mainly attributed to the long diagnostic time required by blood culture. We introduce a diagnostic platform based on T2 magnetic resonance (T2MR), which is capable of sensitive and rapid detection of fungal targets in whole blood. In our approach, blood-compatible polymerase chain reaction is followed by hybridization of the amplified pathogen DNA to capture probe-decorated nanoparticles. Hybridization yields nanoparticle microclusters that cause large changes in the sample's T2MR signal. With this T2MR-based method, Candida spp. can be detected directly in whole blood, thus eliminating the need for analyte purification. Using a small, portable T2MR detection device, we were able to rapidly, accurately, and reproducibly detect five Candida species within human whole blood with a limit of detection of 1 colony-forming unit/ml and a time to result of
- Published
- 2013
- Full Text
- View/download PDF